ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,904Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 117

$731K Total Retail Price of All Prescriptions

Rank: 29 out of 117

665 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 665 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 8,989 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 635 371 S3 1 3
SIMVASTATIN 576 511 2 2
LEVOTHYROXINE SODIUM 556 473 3 1
AMLODIPINE BESYLATE 328 295 4 5
OMEPRAZOLE 317 277 5 9
BENICAR HCT 303 271 6 194
MELOXICAM 296 237 7 70
METFORMIN HCL 261 183 8 15
TRAMADOL HCL 221 192 9 19
GLIPIZIDE 208 175 10 51
BENAZEPRIL-HYDROCHLOROTHIAZIDE 183 168 11 228
METOPROLOL TARTRATE 180 168 12 8
ATORVASTATIN CALCIUM 174 147 13 21
POTASSIUM CHLORIDE 157 150 14 11
LOSARTAN-HYDROCHLOROTHIAZIDE 153 130 15 106
BENAZEPRIL HCL 139 131 16 142
ZOLPIDEM TARTRATE 125 90 17 24
NEXIUM 118 63 18 36
RANITIDINE HCL 116 100 19 43
LANTUS 113 84 20 25
PRAVASTATIN SODIUM 109 92 21 33
LOSARTAN POTASSIUM 104 103 22 32
LISINOPRIL 102 90 23 6
LOVASTATIN 99 89 24 92
TAMSULOSIN HCL 99 91 24 31
ISOSORBIDE MONONITRATE ER 97 91 26 48
DIOVAN HCT 94 82 27 115
FUROSEMIDE 92 83 28 4
GABAPENTIN 92 60 28 12
CLOPIDOGREL 90 82 30 30
NIFEDIPINE ER 87 87 31 116
CITALOPRAM HBR 82 62 32 18
DOXAZOSIN MESYLATE 80 80 33 124
PROAIR HFA 78 63 34 151
PLAVIX 78 73 34 41
HYDRALAZINE HCL 77 75 36 50
DILTIAZEM ER 73 73 37 244
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 56 38 90
BENICAR 72 72 38 211
FINASTERIDE 70 68 40 111
ALENDRONATE SODIUM 70 70 40 26
BUMETANIDE 70 67 40 127
FLUTICASONE PROPIONATE 68 51 43 44
IBUPROFEN 67 33 44 158
ALLOPURINOL 64 56 45 66
INSULIN SYRINGE 64 50 45 138
HYDROCHLOROTHIAZIDE 62 59 47 28
CRESTOR 62 57 47 58
DILTIAZEM 24HR CD 60 53 49 133
GLIPIZIDE ER 59 48 50 143
WARFARIN SODIUM 57 57 51 13
AZITHROMYCIN 57 46 51 64
METOPROLOL SUCCINATE 53 49 53 17
CARISOPRODOL 50 14 R 54 208
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.